Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Weekly cisplatin +/- glutathione in relapsed ovarian carcinoma.
Colombo N, Bini S, Miceli D, Bogliun G, Marzorati L, Cavaletti G, Parmigiani F, Venturino P, Tedeschi M, Frattola L, Buratti C, Mangioni C. Colombo N, et al. Among authors: venturino p. Int J Gynecol Cancer. 1995 Mar;5(2):81-86. doi: 10.1046/j.1525-1438.1995.05020081.x. Int J Gynecol Cancer. 1995. PMID: 11578459
Neuroprotectant drugs in cisplatin neurotoxicity.
Cavaletti G, Cascinu S, Venturino P, Tedeschi M, Tredici G. Cavaletti G, et al. Among authors: venturino p. Anticancer Res. 1996 Sep-Oct;16(5B):3149-59. Anticancer Res. 1996. PMID: 8920783 Review.
An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): data report from Italy.
Tiseo M, Gridelli C, Cascinu S, Crinò L, Piantedosi FV, Grossi F, Brandes AA, Labianca R, Siena S, Amoroso D, Belvedere O, Valentino B, Bearz A, Venturino P, Ardizzoni A. Tiseo M, et al. Among authors: venturino p. Lung Cancer. 2009 May;64(2):199-206. doi: 10.1016/j.lungcan.2008.09.001. Epub 2008 Oct 31. Lung Cancer. 2009. PMID: 18951651 Clinical Trial.
Treatment, rationale, and study design of TALISMAN study: a randomized phase II open-label study of second-line erlotinib versus intermittent erlotinib dosing with docetaxel in the treatment of former-smoker men affected by recurrent squamous non-small-cell lung cancer.
Gridelli C, Rossi A, Venturino P, de Marinis F. Gridelli C, et al. Among authors: venturino p. Clin Lung Cancer. 2011 Jan;12(1):70-3. doi: 10.3816/CLC.2011.n.010. Clin Lung Cancer. 2011. PMID: 21273183 Clinical Trial.
13 results